Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natalya E. Yastrebova"'
Autor:
Nelli K. Akhmatova, Ekaterina A. Kurbatova, Anton E. Zaytsev, Elina A. Akhmatova, Natalya E. Yastrebova, Elena V. Sukhova, Dmitriy V. Yashunsky, Yury E. Tsvetkov, Nikolay E. Nifantiev
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The disaccharide (β-D-glucopyranosyluronic acid)-(1→4)-β-D-glucopyranoside represents a repeating unit of the capsular polysaccharide of Streptococcus pneumoniae serotype 3. A conjugate of the disaccharide with BSA (di-BSA conjugate) adjuvanted w
Externí odkaz:
https://doaj.org/article/f18f737196004c2c9f433de5e4b0e771
Autor:
Ekaterina A. Kurbatova, Nelli K. Akhmatova, Anton E. Zaytsev, Elina A. Akhmatova, Nadezhda B. Egorova, Natalya E. Yastrebova, Elena V. Sukhova, Dmitriy V. Yashunsky, Yury E. Tsvetkov, Nikolay E. Nifantiev
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A number of studies have demonstrated the limited efficacy of S. pneumoniae type 3 capsular polysaccharide (CP) in the 13-valent pneumococcal conjugate vaccine against serotype 3 invasive pneumococcal diseases and carriage. Synthetic oligosaccharides
Externí odkaz:
https://doaj.org/article/d3467d083e4c4dcaac40440a9da2de98
Autor:
Ekaterina A. Kurbatova, Nelli K. Akhmatova, Elina A. Akhmatova, Nadezhda B. Egorova, Natalya E. Yastrebova, Elena V. Sukhova, Dmitriy V. Yashunsky, Yury E. Tsvetkov, Marina L. Gening, Nikolay E. Nifantiev
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Identifying protective synthetic oligosaccharide (OS) epitopes of Streptococcus pneumoniae capsular polysaccharides (CPs) is an indispensable step in the development of third-generation carbohydrate pneumococcal vaccines. Synthetic tetra-, hexa-, and
Externí odkaz:
https://doaj.org/article/ab9f594c3eec4d0da702e251b642934e
Autor:
Alexey A. ryzhov, Aristitsa Mikhailovna Kostinova, Anrey D. Protasov, A.M. Kostinov, Valentina B. Polishhuk, A V Zhestkov, Anna D. Shmit'ko, Elena S. Korovkina, Anna Egorovna Vlasenko, Natalya E. Yastrebova, Michael P. Kostinov
Publikováno v:
Annals of the Russian academy of medical sciences. 76:324-334
Background. Vaccination against pneumococcal infection is one of the priorities in improving the quality of treatment and prevention measures in adults with various pathologies. The effectiveness of vaccination is directly related to the individual
Autor:
Egorova Nb, Nelli Akhmatova, Elina A. Akhmatova, E. V. Sukhova, Yury E. Tsvetkov, Anton E Zaytsev, E. A. Kurbatova, Nikolay E. Nifantiev, Natalya E. Yastrebova, Dmitriy V. Yashunsky
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A number of studies have demonstrated the limited efficacy ofS. pneumoniaetype 3 capsular polysaccharide (CP) in the 13-valent pneumococcal conjugate vaccine against serotype 3 invasive pneumococcal diseases and carriage. Synthetic oligosaccharides (
Autor:
Marina L. Gening, E. V. Sukhova, E. A. Kurbatova, Elina A. Akhmatova, Nikolay E. Nifantiev, Nelli Akhmatova, Yury E. Tsvetkov, Egorova Nb, Natalya E. Yastrebova, Dmitriy V. Yashunsky
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Identifying protective synthetic oligosaccharide (OS) epitopes of Streptococcus pneumoniae capsular polysaccharides (CPs) is an indispensable step in the development of third-generation carbohydrate pneumococcal vaccines. Synthetic tetra-, hexa-, and
Autor:
Ekaterina A, Kurbatova, Nelli K, Akhmatova, Elina A, Akhmatova, Nadezhda B, Egorova, Natalya E, Yastrebova, Elena V, Sukhova, Dmitriy V, Yashunsky, Yury E, Tsvetkov, Marina L, Gening, Nikolay E, Nifantiev
Publikováno v:
Frontiers in Immunology
Identifying protective synthetic oligosaccharide (OS) epitopes of Streptococcus pneumoniae capsular polysaccharides (CPs) is an indispensable step in the development of third-generation carbohydrate pneumococcal vaccines. Synthetic tetra-, hexa-, and